{"id":10265,"date":"2019-11-18T10:18:46","date_gmt":"2019-11-18T09:18:46","guid":{"rendered":"https:\/\/www.gsk.de\/?p=10265"},"modified":"2021-09-08T14:01:38","modified_gmt":"2021-09-08T12:01:38","slug":"die-sicherstellung-der-investability-bei-wachstumsunternehmen","status":"publish","type":"post","link":"https:\/\/gsk.de\/de\/die-sicherstellung-der-investability-bei-wachstumsunternehmen\/","title":{"rendered":"Die Sicherstellung der \u201eInvestability\u201c bei Wachstumsunternehmen"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Gastartikel von Dr. Thomas Derlin in Venture Capital \u201eStart-up 2020\u201c: Warum Wachstumsunternehmen fr\u00fchzeitig Regelungen f\u00fcr die Durchf\u00fchrung zuk\u00fcnftiger Finanzierungsrunden treffen sollten. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gastartikel von Dr. Thomas Derlin in Venture Capital \u201eStart-up 2020\u201c: Warum Wachstumsunternehmen fr\u00fchzeitig Regelungen f\u00fcr die Durchf\u00fchrung zuk\u00fcnftiger Finanzierungsrunden treffen sollten.<\/p>\n","protected":false},"author":32,"featured_media":5286,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[282],"tags":[606,555,567],"ausgabe":[669],"verknuepfung":[725,742],"class_list":["post-10265","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pressespiegel","tag-corporate","tag-gesellschaftsrecht","tag-private-equity-venture-capital","ausgabe-gsk","verknuepfung-gesellschaftsrecht","verknuepfung-private-equity-venture-capital"],"acf":{"ansprechpartner":[{"anwalt":804}],"postdownloads":[{"download":"https:\/\/gsk.de\/wp-content\/uploads\/2019\/11\/VentureCapital-Magazin-Sonderausgabe-Start-up-2020-DER-Wegweiser-fuer-Gruender.pdf","anzeigetitel":""}]},"info":{"date":"18.11.2019","author":"GSK Sysop","categories_names":["Pressespiegel"],"category":"Pressespiegel"},"wpml_main_post_id":10265,"featured_img_src":"https:\/\/gsk.de\/wp-content\/uploads\/2019\/10\/Fallback-Pressespiegel-1.jpg","_links":{"self":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/posts\/10265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/comments?post=10265"}],"version-history":[{"count":0,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/posts\/10265\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/media\/5286"}],"wp:attachment":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/media?parent=10265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/categories?post=10265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/tags?post=10265"},{"taxonomy":"ausgabe","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/ausgabe?post=10265"},{"taxonomy":"verknuepfung","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/verknuepfung?post=10265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}